دواعي استعمال تورميل 10مجم 10 اقراص

Solifenacin succinate 10 mg film-coated tablets, pack of 10, by European Egyptian Pharm. Ind.

• علاج فرط نشاط المثانة لدى البالغين المصحوب بسلس البول الإلحاحي والإلحاح وكثرة التبول.DailyMed (U.S. National Library of Medicine)

• Expected antimuscarinic adverse reactions: dry mouth, constipation, blurred vision, urinary retention and dry eyes; dry mouth and constipation more frequent with 10 mg than 5 mg.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or hypersensitivity to solifenacin succinate or excipients.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Angioedema and anaphylactic reactions, possibly life-threatening; discontinue if tongue/hypopharynx/larynx involvement.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Not recommended in clinically significant bladder outlet obstruction or decreased GI motility.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Antimuscarinic CNS effects (headache, confusion, hallucinations, somnolence); advise caution driving until effects known.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Use with caution in patients treated for narrow-angle glaucoma.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Strong CYP3A4 inhibitors (e.g., ketoconazole)Significantly increased solifenacin exposure; do not exceed 5 mg once daily.DailyMed (U.S. National Library of Medicine)

• No studies in pregnant women; no adverse developmental outcomes in mice at 1.2x MRHD exposure, but developmental toxicity at >=3.6x MRHD.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk; solifenacin is present in mouse milk; weigh benefits of breastfeeding against potential adverse effects.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• سوليفيناسين سكسينات: Competitive muscarinic receptor antagonist (US label 12.1).مضاد تنافسي لمستقبلات المسكارين